- Home
- NCLH vs CORT Comparison
NCLH vs CORT Comparison
Compare NCLH & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCLH
- CORT
- Stock Information
- Founded
- NCLH 1966
- CORT 1998
- Country
- NCLH United States
- CORT United States
- Employees
- NCLH N/A
- CORT N/A
- Industry
- NCLH Marine Transportation
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- NCLH Consumer Discretionary
- CORT Health Care
- Exchange
- NCLH Nasdaq
- CORT Nasdaq
- Market Cap
- NCLH 11.5B
- CORT 7.6B
- IPO Year
- NCLH 2013
- CORT N/A
- Fundamental
- Price
- NCLH $26.66
- CORT $72.87
- Analyst Decision
- NCLH Buy
- CORT Strong Buy
- Analyst Count
- NCLH 19
- CORT 4
- Target Price
- NCLH $28.33
- CORT $139.00
- AVG Volume (30 Days)
- NCLH 16.5M
- CORT 658.4K
- Earning Date
- NCLH 10-30-2025
- CORT 10-29-2025
- Dividend Yield
- NCLH N/A
- CORT N/A
- EPS Growth
- NCLH 61.59
- CORT N/A
- EPS
- NCLH 1.54
- CORT 1.11
- Revenue
- NCLH $9,560,994,000.00
- CORT $716,080,000.00
- Revenue This Year
- NCLH $8.20
- CORT $30.62
- Revenue Next Year
- NCLH $10.43
- CORT $37.68
- P/E Ratio
- NCLH $17.30
- CORT $65.38
- Revenue Growth
- NCLH 5.22
- CORT 25.71
- 52 Week Low
- NCLH $14.21
- CORT $35.45
- 52 Week High
- NCLH $29.29
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- NCLH 62.92
- CORT 56.90
- Support Level
- NCLH $24.36
- CORT $67.32
- Resistance Level
- NCLH $26.28
- CORT $72.52
- Average True Range (ATR)
- NCLH 0.81
- CORT 2.19
- MACD
- NCLH 0.11
- CORT 0.36
- Stochastic Oscillator
- NCLH 83.90
- CORT 74.30
About NCLH Norwegian Cruise Line Holdings Ltd.
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 71,000). It operates 34 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 38,400 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.